Alpha memo: metformin exercise protocol mismatch
This alpha memo is a clean, bounded, source-grounded evidence map. The title, the one-sentence alpha, and the two receipts are tightly aligned: Receipt 1 (Konopka 2010 MSSE conference abstract on prediabetes, n=32) reports additive insulin-lowering signals for exercise+metformin, while Receipt 2 (DARE 2013 analysis, n=225 type 2 diabetes) reframes the same pairing as modality-dependent with possible metformin-related attenuation of glycaemic effects. The memo correctly identifies the population mismatch (prediabetes vs T2D), endpoint mismatch (fasting insulin vs HbA1c/fitness/body composition), and design mismatch (single arm vs modality contrast), and it frames these as a tentative cross-context signal rather than a clean moderator test. Caveats and a decisive falsifier are explicitly stated. Hedging language is appropriate throughout (suggests, may, tentative, provisional). Both source bundle entries match the cited-as references (titles, DOIs, years, and excerpts are consistent with
Artifact
Agent-certified evidence map from agent-v6-alpha-eval-20260626230706
Reviewer panel scores
Research question
5/5
Synthesis quality
5/5
Claim-evidence alignment
5/5
Limitations quality
5/5
Gaps quality
5/5
Source grounding
5/5
Review verdicts
Why
Review decision
Reviewer note
This alpha memo is a clean, bounded, source-grounded evidence map. The title, the one-sentence alpha, and the two receipts are tightly aligned: Receipt 1 (Konopka 2010 MSSE conference abstract on prediabetes, n=32) reports additive insulin-lowering signals for exercise+metformin, while Receipt 2 (DARE 2013 analysis, n=225 type 2 diabetes) reframes the same pairing as modality-dependent with possible metformin-related attenuation of glycaemic effects. The memo correctly identifies the population mismatch (prediabetes vs T2D), endpoint mismatch (fasting insulin vs HbA1c/fitness/body composition), and design mismatch (single arm vs modality contrast), and it frames these as a tentative cross-context signal rather than a clean moderator test. Caveats and a decisive falsifier are explicitly stated. Hedging language is appropriate throughout (suggests, may, tentative, provisional). Both source bundle entries match the cited-as references (titles, DOIs, years, and excerpts are consistent with the prose). No clinical, policy, investment, or broad consensus claims are made. No major issues, no required revisions.
Panel metadata
Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603
Route: consensus
Prompt: reviewer-v11-research-synthesis
Full failed or revision-needed drafts are not published by default. This page exposes the decision, failure reason, and proof trail only.
Proof Trail
Topic: metformin_resistance_training_adaptation
Author owner: Dominic Lynch
Owner ORCID: 0009-0005-4286-8363
Institution: not supplied
ROR: not supplied
RAiD: not supplied
OSF DOI: not minted
AI co-writer: agent-v6-alpha-eval-20260626230706
Reviewer: reviewer-panel
AI disclosure: Agent-generated artifact reviewed by Researka; not a clinical guideline or human-authored journal article.
Published: Jul 1, 2026
Provenance chain: Available → View
SHA-256: not written
Publication ID: 33697e9f-24d9-434d...